Corporate Governance Changes In The Two Largest Economies: What\u27s Happening In The U.S. And Japan?

Lawmakers in the world\u27s two largest economies, the United States and Japan, have enacted legislation to require firms to at least consider altering their governance structure. In the United States, the 2002 Sarbanes-Oxley Act (SOX) and Securities and Exchange Commission (SEC) rules have led to revised governance structures at the 30 Dow Jones (DJ) companies. The governance changes affect the composition, size and functions of the board of directors and its relations with the chief executive officer (CEO). A 2003 change in the Japanese Commercial Code provided firms with three governance options, including a Company with Committees system similar to that found in U.S. firms. Japanese firms now have three governance options available and each, particularly the new Company with Committees system, is examined here along with the reasons why firms either change or decide not to do so. We endorse allowing firms to adopt different governance systems to accommodate special needs as well as country, corporate and cultural concerns. Greater use of independent directors and the separation of the CEO and Chairman roles by firms in both countries would enhance corporate governance

Clinical Characteristics of Hyponatremia

Background & aims : We investigated the contributing factors of hyponatremia in patients on nutrition support using bioelectrical impedance analysis (BIA). Methods : Thirty patients administered enteral or parenteral nutrition support for at least 72 hours were studied. We collected nutritional and electrolyte intake, serum biochemical parameters, and body composition measured by BIA. Patients were classified into two groups according to their serum sodium levels : (1) Normanatremia group, 135–145 mEq / L (n = 18) and (2) Hyponatremia group, less than 135 mEq / L (n = 12), and their characteristics were analyzed. Results : There were no significant differences between the Normonatremia and Hyponatremia groups in terms of energy, protein, and sodium intake. Serum biochemical parameters other than serum sodium and chloride levels were comparable between the two groups. On the other hand, the ratio of extracellular water to total body water (ECW / TBW) obtained by BIA was significantly higher in the Hyponatremia group than in the Normonatremia group. Further, an elevated ECW / TBW significantly and negatively correlated with serum albumin level. Conclusions : Regardless of sodium intake, higher ECW / TBW was associated with hyponatremia in patients on nutrition support. ECW / TBW may be an important clinical parameter relevant to the nutritional care of hyponatremia

Geometry Optimization of Turbine Blade with Surface Injection

ABSTRACT We have been investigating a new cycle concept for advanced propulsion system, in which hydrogen gas is directly injected from turbine blade surfaces and combusted within turbine blade passages. However, in the previous studies, we found that the aerodynamic performance of the blade is largely deteriorated due to the fuel injection. For the purpose of realizing our concept, turbine blade is required to have the adequate performance even with the hydrogen injection. In the present study, we develop a geometry optimization procedure for turbine blade with air injection. Our procedure is based on the gradient method, and composed of some elements, including CFD, geometry modification and automatic design point arrangement, in which design points are automatically clustered around the complicated surface. The validity of our approach is demonstrated by applying the geometry optimization to 2 types of turbine blades with different injection patterns

Silent-speech enhancement using body-conducted vocal-tract resonance signals

The physical characteristics of weak body-conducted vocal-tract resonance signals called non-audible murmur (NAM) and the acoustic characteristics of three sensors developed for detecting these signals have been investigated. NAM signals attenuate 50 dB at 1 kHz; this attenuation consists of 30-dB full-range attenuation due to air-to-body transmission loss and 10 dB/octave spectral decay due to a sound propagation loss within the body. These characteristics agree with the spectral characteristics of measured NAM signals. The sensors have a sensitivity of between 41 and 58 dB [V/Pa] at I kHz, and the mean signal-to-noise ratio of the detected signals was 15 dB. On the basis of these investigations, three types of silent-speech enhancement systems were developed: (1) simple, direct amplification of weak vocal-tract resonance signals using a wired urethane-elastomer NAM microphone, (2) simple, direct amplification using a wireless urethane-elastomer-duplex NAM microphone, and (3) transformation of the weak vocal-tract resonance signals sensed by a soft-silicone NAM microphone into whispered speech using statistical conversion. Field testing of the systems showed that they enable voice impaired people to communicate verbally using body-conducted vocal-tract resonance signals. Listening tests demonstrated that weak body-conducted vocal-tract resonance sounds can be transformed into intelligible whispered speech sounds. Using these systems, people with voice impairments can re-acquire speech communication with less effort. (C) 2009 Elsevier B.V. All rights reserved.ArticleSPEECH COMMUNICATION. 52(4):301-313 (2010)journal articl

Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention increases the risk of bleeding. We studied the safety and clinical outcomes of switching from DAPT to aspirin monotherapy at 3 months after ZES implantation. We retrospectively evaluated 168 consecutive patients with coronary artery disease who had been implanted with a ZES from June 2009 through March 2010. After excluding 40 patients according to exclusion criteria such as myocardial infarction, 128 patients were divided into a 3-month DAPT group (67 patients, 88 lesions) and a 12-month conventional DAPT group (61 patients, 81 lesions). Coronary angiographic followup and clinical followup were conducted at more than 8 months and at 12 months after ZES implantation, respectively. Minor and major bleeding events, stent thrombosis (ST), and major adverse cardiac events (MACE) (death, myocardial infarction, cerebrovascular accident, target lesion revascularization, and target vessel revascularization) were evaluated. There were no statistically significant differences in the incidences of ST and MACE between the two groups. The incidence of bleeding events was significantly lower in the 3-month group than in the 12-month group (1.5% versus 11.5%, ). DAPT can be safely discontinued at 3 months after ZES implantation, which reduces bleeding risk

Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease

Patients with chronic liver disease (CLD) often develops glucose intolerance. We explored the prevalence of diabetes mellitus in viral CLD, and analyzed factors profoundly affecting the diabetic angiopathies. 229 CLD patients (124 chronic hepatitis and 105 liver cirrhosis) entered the study. The diagnosis of diabetes was made with the criteria by World Health Organization. Laboratory investigation included serum asparate aminotransferase, alanine aminotransferase, albumin, fasting blood sugar, hemoglobin A1c (HbA1c), fasting immunoreactive insulin, and HOMA-R (FBS*IRI/405). The incidence of macro- and microangiopathy were also examined. Forty (17.5%) CLD patients were diagnosed diabetes, giving a significantly higher incidence than that of general cohort (5.3%) (p<0.001). Among them, 12 (30%) had the triopathy, significantly lower than that in a matched group of diabetic patients without CLD (65%) (p<0.001). Significantly increased levels of HbA1c and HOMA-R were observed in diabetic CLD with angiopathy compared with diabetic CLD without. Incidence of diabetes was increased in viral CLD patients. The rate of diabetic angiopathies in CLD, however, was relatively low, this could be explained by low coagulability in these patients. Poor control of hyperglycemia, partly due to insulin resistance, might explain the onset of angiopathy in diabetic CLD